股静脉转位动静脉瘘用于废弃上肢透析通路的长期结局
该回顾性研究纳入21例因上肢透析通路耗尽而接受股静脉转位动静脉瘘的患者,平均既往失败通路5.3±2.8次、透析龄6.1±4.9年。技术成功率100%,1、3、5年一期通畅率分别为93%、74%、74%,二期通畅率分别为100%、89%、89%。结论认为该术式是上肢通路耗尽患者的可行替代选择,长期通畅性良好。
要点
- 股静脉转位动静脉瘘技术成功率100%,1、3、5年一期通畅率93%、74%、74%。
- 二期通畅率1年100%、3年89%、5年89%,长期通畅性良好。
- 术后并发症包括骨筋膜室综合征需筋膜切开2例、伤口并发症6例。
核心结论
- 股静脉转位动静脉瘘是上肢透析通路耗尽患者的可行替代选择,长期通畅性良好。
研究设计与样本
- 回顾性分析21例接受股静脉转位动静脉瘘的透析患者,平均既往失败通路5.3±2.8次、透析龄6.1±4.9年。
- 手术方式为游离股静脉并将其转位吻合至收肌管水平股浅动脉远端。
主要发现
- 技术成功率为100%,16例(76.2%)出院时接受抗凝治疗。
- 1、3、5年一期通畅率分别为93%、74%、74%,二期通畅率分别为100%、89%、89%。
- 2例发生骨筋膜室综合征需筋膜切开,6例出现伤口并发症。
临床怎么用
- 对于上肢透析通路耗尽且存在严重中心静脉狭窄的患者,可考虑股静脉转位动静脉瘘作为替代通路。
- 术后需关注骨筋膜室综合征和伤口并发症,部分患者出院时接受抗凝治疗。
局限性
- 回顾性设计,样本量仅21例,长期通畅率数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The number and longevity of patients with end-stage renal disease requiring dialysis access have continued to increase, leading to challenging situations, including exhausted upper extremity access and severe central venous stenosis. This has led to an increase in the use of alternative access sites, including the lower extremities. The transposed femoral vein arteriovenous fistula for dialysis access is a previously described alternative, although limited data are available on its long-term patency. METHODS: Patients treated with a transposed femoral vein fistula were retrospectively reviewed. A transposed femoral vein fistula was created by harvesting the femoral vein and transposing it to the distal superficial femoral artery at the level of the adductor canal. The demographic information, perioperative characteristics, complications, and long-term outcomes were recorded and analyzed. RESULTS: A total of 21 patients had undergone transposed femoral vein fistula for dialysis access after an average of 5.3 ± 2.8 failed dialysis access procedures and a duration of 6.1 ± 4.9 years from the initiation of dialysis. The average age at the procedure was 53.5 ± 12.8 years. Ten patients (47.6%) had a history of diabetes mellitus and nine (42.9%) had a history of coronary artery disease. Technical success was achieved in 100% of cases, and 16 patients (76.2%) were discharged with anticoagulation therapy. The primary patency at 1, 3, and 5 years was 93%, 74%, and 74%, respectively. The secondary patency at 1, 3, and 5 years was 100%, 89%, and 89%, respectively. Two patients had compartment syndrome requiring fasciotomy, and six patients experienced wound complications. CONCLUSIONS: Transposed femoral vein fistula for dialysis access is a viable alternative for patients with an exhausted upper extremity access, with good long-term patency.
引用
- Orion KC, Kim TI, Rizzo AN, et al. Long-term outcomes of transposed femoral vein arteriovenous fistula for abandoned upper extremity dialysis access. J Vasc Surg. 2021. PMID: 33348002. doi:10.1016/j.jvs.2020.12.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。